ITOC
iTonic Holdings Ltd.
NASDAQ: ITOC · HEALTHCARE · MEDICAL DEVICES
$0.36
-2.00% today
Updated 2026-04-30
Market cap
$6.91M
P/E ratio
—
P/S ratio
13.20x
EPS (TTM)
$-0.32
Dividend yield
—
52W range
$0 – $1
Volume
4.1M
iTonic Holdings Ltd. (ITOC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $702776.00 | $679777.00 | $628591.00 | $448196.00 | $523031.00 |
| Revenue growth (YoY) | — | -3.3% | -7.5% | -28.7% | +16.7% |
| Cost of revenue | $112033.00 | $121627.00 | $157763.00 | $103256.00 | $195680.00 |
| Gross profit | $590743.00 | $558150.00 | $470828.00 | $344939.00 | $327351.00 |
| Gross margin | 84.1% | 82.1% | 74.9% | 77.0% | 62.6% |
| R&D | $81220.00 | $73717.00 | $84474.00 | $93324.00 | $459135.00 |
| SG&A | $371437.00 | $456912.00 | $693034.00 | $1.06M | $5.06M |
| Operating income | $138086.00 | $27521.00 | $-306680.00 | $-770266.00 | $-5.16M |
| Operating margin | 19.6% | 4.0% | -48.8% | -171.9% | -987.5% |
| EBITDA | $269478.00 | $125115.00 | $-197376.00 | $-566325.00 | — |
| EBITDA margin | 38.3% | 18.4% | -31.4% | -126.4% | 0.0% |
| EBIT | $203526.00 | $71031.00 | $-260510.00 | $-638756.00 | — |
| Interest expense | — | — | — | — | — |
| Income tax | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $192462.00 | $83980.00 | $-241217.00 | $-660588.00 | $-5.10M |
| Net income growth (YoY) | — | -56.4% | -387.2% | -173.9% | -671.7% |
| Profit margin | 27.4% | 12.4% | -38.4% | -147.4% | -974.7% |